tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MYGN is currently covered by 6 analysts with an average price target of $22.21. This is a potential upside of $3.29 (17.39%) from yesterday's end of day stock price of $18.92.
Myriad Genetics's activity chart (see below) currently has 130 price targets and 85 ratings on display. The stock rating distribution of MYGN is 42.86% HOLD, 35.71% BUY and 21.43% SELL.
Analysts average stock forecasts to be materialized ratio is 78.1% with an average time for these price targets to be met of 190.53 days.
Highest price target for MYGN is $31, Lowest price target is $14, average price target is $22.21.
Most recent stock forecast was given by MATTHEW SYKES from GOLDMAN SACHS on 29-Jan-2024. First documented stock forecast 24-Oct-2012.
3/26/09 2 for 1
9/12/00 2 for 1
Currently out of the existing stock ratings of MYGN, 6 are a HOLD (42.86%), 5 are a BUY (35.71%), 3 are a SELL (21.43%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
31
$10.66 (52.41%)
28
2 months 21 days ago
2/5 (40%)
$8.28 (36.44%)
93
Buy
4 months 6 days ago
6/6 (100%)
$2.9 (9.63%)
117
Sell
14
$-6.34 (-31.17%)
17
5 months 12 days ago
1/2 (50%)
$-3.76 (-21.17%)
2
Hold
24
$3.66 (17.99%)
22
1 years 1 months 13 days ago
1/2 (50%)
$1.91 (8.65%)
148
Hold
27
$6.66 (32.74%)
25
1 years 1 months 16 days ago
0/2 (0%)
$3.74 (16.08%)
What is MYGN (Myriad Genetics) average time for price targets to be met?
Which analyst has the current highest performing score on MYGN (Myriad Genetics) with a proven track record?
Which analyst has the most public recommendations on MYGN (Myriad Genetics)?
Which analyst is the currently most bullish on MYGN (Myriad Genetics)?
Which analyst is the currently most reserved on MYGN (Myriad Genetics)?
